Patents by Inventor David C. Peterson

David C. Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inter-oxa-12,13(E)-didehydro-13,14-dihydro-9,10-didehydro-9-deoxy-PGD.sub.1
    Patent number: 4136109
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: January 23, 1979
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 12,13(E)-Didehydro-13,14-dihydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4125547
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 14, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 12,13(E)-Didehydro-13,14-dihydro-9,10-didehydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4125548
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 14, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 12,13(E)-Didehydro-13,14-dihydro-9,10-didehydro-9-deoxy-PGD.sub.2 compounds
    Patent number: 4125546
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 14, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • Inter-oxa-12,13(E)-didehydro-13,14-dihydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4124625
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • Cis-4,5-didehydro-12,13(e)-didehydro-13,14-dihydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4124621
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 12,13(E)-Didehydro-13,14-dihydro-PGD.sub.2 compounds
    Patent number: 4124610
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 12,13(E)-didehydro-13,14-dihydro-PGD.sub.1 compounds
    Patent number: 4124611
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and process for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • Cis-4,5-didehydro-12,13(E)-didehydro-13 ,14-dihydro-9,10-didehydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4124622
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 12,13(E)-didehydro-13,14-dihydro-9-deoxy-PGD.sub.2 compounds
    Patent number: 4124614
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 9-Deoxy-PGD.sub.1 compounds
    Patent number: 4124613
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 9-Deoxy-PGD.sub.2 compounds
    Patent number: 4124612
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • Cis-4,5-didehydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4124620
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • Inter-oxa-9-deoxy-PGD.sub.1 compounds
    Patent number: 4124624
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particlarly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • Inter-oxa-12,13(E)-didehydro-13,14-dihydro-PGD.sub.1 compounds
    Patent number: 4124623
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharamcological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: November 7, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • Cis-4,5-didehydro-12,13(E)didehydro-13,14-dihydro-PGD.sub.1 compounds
    Patent number: 4122105
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostanglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: October 24, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 3,7-Inter-m-phenylene-4,5,6-trinor-12,13(E)-didehydro-13,14-di hydro-9,10-didehydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4119786
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: October 10, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 3,7-Inter-m-phenylene-4,5,6-trinor-12,1 3(E)-didehydro-13,14-dihydro-9-deoxy-PGD.sub.1 compounds
    Patent number: 4119785
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: October 10, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson
  • 3,7-Inter-m-phenylene-4,5,6-trinor-PGD.sub.1 compounds
    Patent number: 4118591
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: October 3, 1978
    Assignees: The Upjohn Company, The Upjohn Company
    Inventor: David C. Peterson
  • 3,7-Inter-m-phenylene-4,5,6-trinor-12,13(e)-didehydro-13,14-dehydro-PGD.sub .
    Patent number: 4099014
    Abstract: Prostaglandin analogs with the following cyclopentane ring structure: ##STR1## are disclosed along with intermediates useful in their preparation and processes for their preparation. These analogs are useful for some of the same pharmacological purposes as the prostaglandins, particularly and especially as blood platelet aggregation inhibitors.
    Type: Grant
    Filed: June 23, 1977
    Date of Patent: July 4, 1978
    Assignee: The Upjohn Company
    Inventor: David C. Peterson